Showing results (2561-2570 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|July 1, 1997
Gene transfer of a hybrid interleukin-1 beta gene to B16 mouse melanoma recruits leucocyte subsets and reduces tumour growth in vivoO Björkdahl, A G Wingren, G Hedhund, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1997
The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependentS Mori, A Jewett, K Murakami-Mori, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1997
Role of macrophage-colony-stimulating factor in regulating the accumulation and phenotype of tumor-associated macrophagesS T Dougherty, C J Eaves, W H McBride, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1997
Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22R M Sharkey, T M Behr, M J Mattes, et al.
Cancer Immunology, Immunotherapy : CII|April 1, 1997
Rapid elimination of mouse/human chimeric monoclonal antibodies in nude miceF B van Gog, R H Brakenhoff, G B Snow, et al.
Cancer Immunology, Immunotherapy : CII|April 1, 1997
Interleukin-2 secretion by KHT sarcoma cells leads to loss of their vaccine potentialS C Hsu, D Glaves, A K Sood
Cancer Immunology, Immunotherapy : CII|December 20, 2005
Characterization of IL-2-activated TILs and their use in intrapericardial immunotherapy in malignant pericardial effusionUhi Toh, Teruhiko Fujii, Naoko Seki, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2005
Tumor escape mechanisms in prostate cancerAshley M Miller, Pavel Pisa
Cancer Immunology, Immunotherapy : CII|October 31, 2009
Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant settingMatthias May, Sabine Brookman-May, Bernd Hoschke, et al.
Pageof 652